The global ECG patch and holter monitor market was estimated to be USD 1.53 billion in 2023 and is expected to reach at USD 10.95 billion by 2034 with a CAGR of 19.59% during the forecast period 2024-2034. Increasing prevalence of atrial fibrillation, growing elderly population, higher rates of cardiovascular conditions, shift towards ambulatory monitoring devices, rising technological advancements, surge in investments in early arrhythmia detection, increasing advancements in telemetry technology, rise in launch of novel devices, and surge in approvals for innovative ECG patch and holter monitor devices are some of the key factors boosting the market growth.
Surge in approvals for innovative ECG patch and holter monitor devices is predicted to boost the market growth during the forecast period. Continuous ECG monitoring is favored over standard inpatient ECG monitoring for obtaining precise results. Standard ECG tests often fail to yield definitive diagnoses, necessitating additional investigations. To prevent such scenarios, ECG patches and Holter monitors are utilized. In September 2023, The FDA has approved SmartCardia's cloud platform and 7-lead real-time ECG monitoring patch. The 7L patch from SmartCardia is comfortable to wear, wireless, waterproof, and allows for continuous monitoring for a duration of up to 14 days.
By product, holter monitors was the highest revenue-grossing segment in the global ECG patch and holter monitor market in 2023 owing to the increased precision, user-friendliness, & ongoing monitoring capabilities aid in identifying uncommon arrhythmias, advancements in technology, and surge in new product releases offering real-time results. Additionally, ECG patch is predicted to grow at the fastest CAGR during the forecast period as they are leadless & user-friendly. ECG patches offer minimal disruption to daily routines, are hygienic due to their non-reusability, and are resistant to water. Unlike Holter monitors, there is no initial investment required for the device, and they are convenient to apply with no maintenance needed. Moreover, the anticipated increase in product launches is expected to fuel growth in this segment. For instance, in May 2023, VTT Technical Research Centre of Finland has created a novel eco-friendly electrocardiogram (ECG or EKG) patch composed of biodegradable materials and entirely recyclable. This patch features a modular design, allowing for the effortless removal and reuse of electronic components from the disposable patch.
By application, diagnosis was the highest revenue-grossing segment in the global ECG patch and holter monitor market in 2023 owing to the rise in atrial fibrillation cases, increasing demand for advanced diagnostic devices for early detection. Additionally, monitoring is predicted to grow at the fastest CAGR during the forecast period owing to increased precision, continuous monitoring for identifying uncommon arrhythmias, advancements in technology, and surge in new product launches. For instance, in September 2023, In the US, iRhythm Technologies, Inc. has updated its Zio long-term continuous monitoring (LTCM) service and unveiled its newest Zio monitor.
By end-user, hospitals & clinics was the highest revenue-grossing segment in the global ECG patch and holter monitor market in 2023 owing to the presence of advanced infrastructure, accessibility to state-of-the-art devices, increase in both practitioners & patients, and growing partnerships aimed at reducing the burden of diagnosis & treatment. Additionally, Ambulatory facilities is predicted to grow at the fastest CAGR during the forecast period owing to the rising advancements in technology, growing preference for ambulatory treatment centers, increasing number of patients choosing to undergo diagnosis in these facilities, and heightened emphasis on the innovation of medical devices. For instance, in November 2023, A team at RMIT University has developed a wearable ECG device designed to prevent heart attacks in individuals with cardiovascular disease, suitable for use in remote healthcare and ambulatory care settings.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing demand for wearable ECG monitoring devices, growing need for early detection of cardiovascular diseases (CVDs) & arrhythmia with reduced false-positive results, rising prevalence of Atrial Fibrillation (AFib), surge in introduction of advanced wireless ECG monitoring devices and rising technological partnerships among manufacturers. For instance, in March 2024, Together with Artella Solutions, Wellysis, a digital healthcare company, is launching a remote cardiac monitoring service in the US. This alliance leverages Wellysis' FDA-cleared S-Patch electrocardiogram monitoring system, which has been upgraded with the S-Patch ExL device. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in the elderly population, increasing prevalence of cardiovascular diseases (CVDs), increasing development of healthcare infrastructure, advancements in technology, preference among patients for ambulatory ECG monitoring, and growing partnerships among industry stakeholders. For instance, in January 2024, India Medtronic Private Limited revealed a strategic partnership with Cardiac Design Labs (CDL) to introduce, expand, and enhance access to CDL’s innovative diagnostic technology, Padma Rhythms. This technology comprises an external loop recorder (ELR) patch aimed at facilitating comprehensive, long-term heart monitoring and diagnosis.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Surge in approvals for innovative ECG patch and holter monitor devices is predicted to boost the market growth during the forecast period. Continuous ECG monitoring is favored over standard inpatient ECG monitoring for obtaining precise results. Standard ECG tests often fail to yield definitive diagnoses, necessitating additional investigations. To prevent such scenarios, ECG patches and Holter monitors are utilized. In September 2023, The FDA has approved SmartCardia's cloud platform and 7-lead real-time ECG monitoring patch. The 7L patch from SmartCardia is comfortable to wear, wireless, waterproof, and allows for continuous monitoring for a duration of up to 14 days.
By product, holter monitors was the highest revenue-grossing segment in the global ECG patch and holter monitor market in 2023 owing to the increased precision, user-friendliness, & ongoing monitoring capabilities aid in identifying uncommon arrhythmias, advancements in technology, and surge in new product releases offering real-time results. Additionally, ECG patch is predicted to grow at the fastest CAGR during the forecast period as they are leadless & user-friendly. ECG patches offer minimal disruption to daily routines, are hygienic due to their non-reusability, and are resistant to water. Unlike Holter monitors, there is no initial investment required for the device, and they are convenient to apply with no maintenance needed. Moreover, the anticipated increase in product launches is expected to fuel growth in this segment. For instance, in May 2023, VTT Technical Research Centre of Finland has created a novel eco-friendly electrocardiogram (ECG or EKG) patch composed of biodegradable materials and entirely recyclable. This patch features a modular design, allowing for the effortless removal and reuse of electronic components from the disposable patch.
By application, diagnosis was the highest revenue-grossing segment in the global ECG patch and holter monitor market in 2023 owing to the rise in atrial fibrillation cases, increasing demand for advanced diagnostic devices for early detection. Additionally, monitoring is predicted to grow at the fastest CAGR during the forecast period owing to increased precision, continuous monitoring for identifying uncommon arrhythmias, advancements in technology, and surge in new product launches. For instance, in September 2023, In the US, iRhythm Technologies, Inc. has updated its Zio long-term continuous monitoring (LTCM) service and unveiled its newest Zio monitor.
By end-user, hospitals & clinics was the highest revenue-grossing segment in the global ECG patch and holter monitor market in 2023 owing to the presence of advanced infrastructure, accessibility to state-of-the-art devices, increase in both practitioners & patients, and growing partnerships aimed at reducing the burden of diagnosis & treatment. Additionally, Ambulatory facilities is predicted to grow at the fastest CAGR during the forecast period owing to the rising advancements in technology, growing preference for ambulatory treatment centers, increasing number of patients choosing to undergo diagnosis in these facilities, and heightened emphasis on the innovation of medical devices. For instance, in November 2023, A team at RMIT University has developed a wearable ECG device designed to prevent heart attacks in individuals with cardiovascular disease, suitable for use in remote healthcare and ambulatory care settings.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing demand for wearable ECG monitoring devices, growing need for early detection of cardiovascular diseases (CVDs) & arrhythmia with reduced false-positive results, rising prevalence of Atrial Fibrillation (AFib), surge in introduction of advanced wireless ECG monitoring devices and rising technological partnerships among manufacturers. For instance, in March 2024, Together with Artella Solutions, Wellysis, a digital healthcare company, is launching a remote cardiac monitoring service in the US. This alliance leverages Wellysis' FDA-cleared S-Patch electrocardiogram monitoring system, which has been upgraded with the S-Patch ExL device. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in the elderly population, increasing prevalence of cardiovascular diseases (CVDs), increasing development of healthcare infrastructure, advancements in technology, preference among patients for ambulatory ECG monitoring, and growing partnerships among industry stakeholders. For instance, in January 2024, India Medtronic Private Limited revealed a strategic partnership with Cardiac Design Labs (CDL) to introduce, expand, and enhance access to CDL’s innovative diagnostic technology, Padma Rhythms. This technology comprises an external loop recorder (ELR) patch aimed at facilitating comprehensive, long-term heart monitoring and diagnosis.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Application, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: ECG Patch And Holter Monitor Market Report 2023 - 2034
ECG Patch And Holter Monitor Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Holter Monitors
- ECG Patch
ECG Patch And Holter Monitor Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Monitoring
- Diagnostics
ECG Patch And Holter Monitor Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals & Clinics
- Ambulatory Facilities
- Others
ECG Patch And Holter Monitor Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. ECG Patch And Holter Monitor Market: Product Estimates & Trend Analysis
8. ECG Patch And Holter Monitor Market: Application Estimates & Trend Analysis
9. ECG Patch And Holter Monitor Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America ECG Patch And Holter Monitor Market
12. Europe Global ECG Patch And Holter Monitor Market
13. Asia Pacific Global ECG Patch And Holter Monitor Market
14. Latin America Global ECG Patch And Holter Monitor Market
15. MEA Global ECG Patch And Holter Monitor Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Nissha Medical Technologies (NMT)
- iRhythm Technologies Inc.
- Nihon Kohden Corporation
- Fukuda Denshi Co. Ltd.
- Spacelabs Healthcare
- Lief Therapeutics Inc.
- Koninklijke Philips N.V.
- Nasiff Associates Inc.
- Midmark Corporation
- Bardy Diagnostics Inc.
- Cardiac Insight Inc.
- LifeSignals Inc.
- GE Healthcare
- Medtronic plc
- VitalConnect
- AliveCor Inc.
- Schiller AG
- Hill-Rom
